News summary produced by Claude AI
Health advisers in the UK are now recommending that all teenagers receive a free meningitis B vaccine at approximately age 15, marking a shift from previous guidance on the matter. This recommendation follows an outbreak of meningitis in Kent that occurred earlier in the year, which resulted in 29 confirmed or suspected cases and two fatalities. The Joint Committee on Vaccination and Immunisation based its revised position on recent new evidence indicating that teenagers face elevated risk due to their socially active lifestyles, which can facilitate disease transmission through close contact including kissing and sharing items like vapes.
Currently, babies born on or after 1 July 2015 receive the meningitis B vaccine as part of the routine childhood immunisation programme. However, teenagers and young adults over age 11 have not received this protection. Under the new recommendation, teenagers would receive two doses at age 15, with the exception of those vaccinated as infants, who would need only a single booster dose.
The Department of Health and Social Care stated it would consider the advice and provide updates on any future programme. Implementation decisions will ultimately rest with government ministers in each UK nation, who must evaluate whether the financial costs of providing vaccines through the NHS are justified. A temporary vaccination campaign is already underway during the summer months, offering free meningitis B jabs to young people preparing to enter university.
Meningitis B infection can cause serious complications including meningitis and sepsis, potentially resulting in life-threatening conditions or long-term disabilities such as amputations, hearing loss, and brain damage. Supporters of the recommendation, including individuals who have experienced significant health consequences from the disease and families affected by fatalities, have emphasized the importance of both vaccination and public education about disease signs and symptoms. Pharmacy organisations have indicated readiness to deliver the vaccines as part of the expanded programme.